Engineers Gate Manager’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-2,638
Closed -$48K – 2232
2024
Q4
$48K Buy
+2,638
New +$51.8K ﹤0.01% 2090
2022
Q2
– Sell
-3,283
Closed -$209K – 1974
2022
Q1
$209K Sell
3,283
-336
-9% -$24.1K 0.01% 1605
2021
Q4
$303K Buy
+3,619
New +$406K 0.01% 1399
2020
Q4
– Sell
-3,034
Closed -$484K – 1744
2020
Q3
$484K Sell
3,034
-670
-18% -$121K 0.02% 1011
2020
Q2
$733K Buy
+3,704
New +$680K 0.04% 751
2020
Q1
– Sell
-1,083
Closed -$83K – 1630
2019
Q4
$83K Buy
1,083
+78
+8% +$6.8K ﹤0.01% 1548
2019
Q3
$101K Buy
+1,005
New +$117K 0.01% 1310

Other funds holding CTSO

Engineers Gate Manager's CTSO Position: Q1 2025 in Review

Engineers Gate Manager sold out of Cytosorbents Corp (CTSO) in Q1 2025, closing a stake of 2,638 shares — an estimated $48K sold.

Engineers Gate Manager first reported a position in CTSO in Q3 2019 and held it in 7 quarters. The position peaked at $733K in Q2 2020. 48 funds tracked by Wall St. Rank hold CTSO as of Q1 2025.

  • Engineers Gate Manager reported no remaining Cytosorbents Corp position as of Q1 2025 after selling out during the quarter.
  • Engineers Gate Manager sold 2,638 Cytosorbents Corp shares in Q1 2025, an estimated $48K.
  • Engineers Gate Manager first reported a position in Cytosorbents Corp in Q3 2019 and held it in 7 quarters.
  • Engineers Gate Manager's Cytosorbents Corp position peaked at $733K in Q2 2020.
  • 48 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2025.

Based on Engineers Gate Manager's 13F filing for Q1 2025, filed 15 May 2025.